Prevalenza di anticorpi anticardiolipina e/o anticorpi anti beta 2 glicoproteina I in pazienti con epilessia

Translated title of the contribution: High prevalence of anticardiolipin and/or anti-β2 glycoprotein I antibodies in young patients with epilepsy

M. Viri, R. Cimaz, A. Scarano, M. Lodi, A. Gatti, P. Veggiotti, P. L. Meroni, A. Romeo

Research output: Contribution to journalArticlepeer-review

Abstract

Previous studies have suggest that anticardiolipin (aCL) antibodies can be associated with epilepsy in patients with SLE. We started a prospective study in order to determine the prevalence of aCL and anti-beta2 glycoprotein 1 (beta2-GPI) antibodies in sera of 142 patients with pediatric-onset epilepsy, without signs of autoimmunological diseases. Positive results were found in 44/142 cases (31%). We conclude that aCl and anti-beta2-GPI can be associated with epilepsy even in patients without SLE.

Translated title of the contributionHigh prevalence of anticardiolipin and/or anti-β2 glycoprotein I antibodies in young patients with epilepsy
Original languageItalian
Pages (from-to)213-214
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number106-107
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'High prevalence of anticardiolipin and/or anti-β2 glycoprotein I antibodies in young patients with epilepsy'. Together they form a unique fingerprint.

Cite this